The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gene Editing Technologies Market Research Report 2025
Synopsis
Genome editing is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism.
The global Gene Editing Technologies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gene Editing Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gene Editing Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Gene Editing Technologies in Gene Therapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Gene Editing Technologies include Thermo Fisher Scientific, Merck, Sangamo Therapeutics, Lonza, Transposagen Biopharmaceuticals, Editas Medicine, CRISPR Therapeutics and Agilent Technologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gene Editing Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Editing Technologies.
Report Scope
The Gene Editing Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Editing Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Editing Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Merck
Sangamo Therapeutics
Lonza
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
Agilent Technologies
Segment by Type
Double Strand Break Repair
Engineered Nucleases
Clustered Regularly Interspaced Short Palindromic Repeats
Segment by Application
Gene Therapy
Eradicating Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Editing Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Genome editing is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism.
The global Gene Editing Technologies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gene Editing Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gene Editing Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Gene Editing Technologies in Gene Therapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Gene Editing Technologies include Thermo Fisher Scientific, Merck, Sangamo Therapeutics, Lonza, Transposagen Biopharmaceuticals, Editas Medicine, CRISPR Therapeutics and Agilent Technologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gene Editing Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Editing Technologies.
Report Scope
The Gene Editing Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Editing Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Editing Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Merck
Sangamo Therapeutics
Lonza
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
Agilent Technologies
Segment by Type
Double Strand Break Repair
Engineered Nucleases
Clustered Regularly Interspaced Short Palindromic Repeats
Segment by Application
Gene Therapy
Eradicating Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Editing Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Editing Technologies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Double Strand Break Repair
1.2.3 Engineered Nucleases
1.2.4 Clustered Regularly Interspaced Short Palindromic Repeats
1.3 Market by Application
1.3.1 Global Gene Editing Technologies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Gene Therapy
1.3.3 Eradicating Diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Editing Technologies Market Perspective (2019-2030)
2.2 Gene Editing Technologies Growth Trends by Region
2.2.1 Global Gene Editing Technologies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Editing Technologies Historic Market Size by Region (2019-2024)
2.2.3 Gene Editing Technologies Forecasted Market Size by Region (2025-2030)
2.3 Gene Editing Technologies Market Dynamics
2.3.1 Gene Editing Technologies Industry Trends
2.3.2 Gene Editing Technologies Market Drivers
2.3.3 Gene Editing Technologies Market Challenges
2.3.4 Gene Editing Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Editing Technologies Players by Revenue
3.1.1 Global Top Gene Editing Technologies Players by Revenue (2019-2024)
3.1.2 Global Gene Editing Technologies Revenue Market Share by Players (2019-2024)
3.2 Global Gene Editing Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Editing Technologies Revenue
3.4 Global Gene Editing Technologies Market Concentration Ratio
3.4.1 Global Gene Editing Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Editing Technologies Revenue in 2023
3.5 Gene Editing Technologies Key Players Head office and Area Served
3.6 Key Players Gene Editing Technologies Product Solution and Service
3.7 Date of Enter into Gene Editing Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Editing Technologies Breakdown Data by Type
4.1 Global Gene Editing Technologies Historic Market Size by Type (2019-2024)
4.2 Global Gene Editing Technologies Forecasted Market Size by Type (2025-2030)
5 Gene Editing Technologies Breakdown Data by Application
5.1 Global Gene Editing Technologies Historic Market Size by Application (2019-2024)
5.2 Global Gene Editing Technologies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Editing Technologies Market Size (2019-2030)
6.2 North America Gene Editing Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Editing Technologies Market Size by Country (2019-2024)
6.4 North America Gene Editing Technologies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Editing Technologies Market Size (2019-2030)
7.2 Europe Gene Editing Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Editing Technologies Market Size by Country (2019-2024)
7.4 Europe Gene Editing Technologies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Editing Technologies Market Size (2019-2030)
8.2 Asia-Pacific Gene Editing Technologies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Editing Technologies Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Editing Technologies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Editing Technologies Market Size (2019-2030)
9.2 Latin America Gene Editing Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Editing Technologies Market Size by Country (2019-2024)
9.4 Latin America Gene Editing Technologies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Editing Technologies Market Size (2019-2030)
10.2 Middle East & Africa Gene Editing Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Editing Technologies Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Editing Technologies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Gene Editing Technologies Introduction
11.1.4 Thermo Fisher Scientific Revenue in Gene Editing Technologies Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Gene Editing Technologies Introduction
11.2.4 Merck Revenue in Gene Editing Technologies Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Sangamo Therapeutics
11.3.1 Sangamo Therapeutics Company Detail
11.3.2 Sangamo Therapeutics Business Overview
11.3.3 Sangamo Therapeutics Gene Editing Technologies Introduction
11.3.4 Sangamo Therapeutics Revenue in Gene Editing Technologies Business (2019-2024)
11.3.5 Sangamo Therapeutics Recent Development
11.4 Lonza
11.4.1 Lonza Company Detail
11.4.2 Lonza Business Overview
11.4.3 Lonza Gene Editing Technologies Introduction
11.4.4 Lonza Revenue in Gene Editing Technologies Business (2019-2024)
11.4.5 Lonza Recent Development
11.5 Transposagen Biopharmaceuticals
11.5.1 Transposagen Biopharmaceuticals Company Detail
11.5.2 Transposagen Biopharmaceuticals Business Overview
11.5.3 Transposagen Biopharmaceuticals Gene Editing Technologies Introduction
11.5.4 Transposagen Biopharmaceuticals Revenue in Gene Editing Technologies Business (2019-2024)
11.5.5 Transposagen Biopharmaceuticals Recent Development
11.6 Editas Medicine
11.6.1 Editas Medicine Company Detail
11.6.2 Editas Medicine Business Overview
11.6.3 Editas Medicine Gene Editing Technologies Introduction
11.6.4 Editas Medicine Revenue in Gene Editing Technologies Business (2019-2024)
11.6.5 Editas Medicine Recent Development
11.7 CRISPR Therapeutics
11.7.1 CRISPR Therapeutics Company Detail
11.7.2 CRISPR Therapeutics Business Overview
11.7.3 CRISPR Therapeutics Gene Editing Technologies Introduction
11.7.4 CRISPR Therapeutics Revenue in Gene Editing Technologies Business (2019-2024)
11.7.5 CRISPR Therapeutics Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Detail
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Gene Editing Technologies Introduction
11.8.4 Agilent Technologies Revenue in Gene Editing Technologies Business (2019-2024)
11.8.5 Agilent Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Gene Editing Technologies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Double Strand Break Repair
Table 3. Key Players of Engineered Nucleases
Table 4. Key Players of Clustered Regularly Interspaced Short Palindromic Repeats
Table 5. Global Gene Editing Technologies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Gene Editing Technologies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Gene Editing Technologies Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Gene Editing Technologies Market Share by Region (2019-2024)
Table 9. Global Gene Editing Technologies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Gene Editing Technologies Market Share by Region (2025-2030)
Table 11. Gene Editing Technologies Market Trends
Table 12. Gene Editing Technologies Market Drivers
Table 13. Gene Editing Technologies Market Challenges
Table 14. Gene Editing Technologies Market Restraints
Table 15. Global Gene Editing Technologies Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Gene Editing Technologies Market Share by Players (2019-2024)
Table 17. Global Top Gene Editing Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing Technologies as of 2023)
Table 18. Ranking of Global Top Gene Editing Technologies Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Gene Editing Technologies Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gene Editing Technologies Product Solution and Service
Table 22. Date of Enter into Gene Editing Technologies Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gene Editing Technologies Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Gene Editing Technologies Revenue Market Share by Type (2019-2024)
Table 26. Global Gene Editing Technologies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Gene Editing Technologies Revenue Market Share by Type (2025-2030)
Table 28. Global Gene Editing Technologies Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Gene Editing Technologies Revenue Market Share by Application (2019-2024)
Table 30. Global Gene Editing Technologies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Gene Editing Technologies Revenue Market Share by Application (2025-2030)
Table 32. North America Gene Editing Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Gene Editing Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Gene Editing Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Gene Editing Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Gene Editing Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Gene Editing Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Gene Editing Technologies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Gene Editing Technologies Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Gene Editing Technologies Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Gene Editing Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Gene Editing Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Gene Editing Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Gene Editing Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Gene Editing Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Gene Editing Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Detail
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific Gene Editing Technologies Product
Table 50. Thermo Fisher Scientific Revenue in Gene Editing Technologies Business (2019-2024) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. Merck Company Detail
Table 53. Merck Business Overview
Table 54. Merck Gene Editing Technologies Product
Table 55. Merck Revenue in Gene Editing Technologies Business (2019-2024) & (US$ Million)
Table 56. Merck Recent Development
Table 57. Sangamo Therapeutics Company Detail
Table 58. Sangamo Therapeutics Business Overview
Table 59. Sangamo Therapeutics Gene Editing Technologies Product
Table 60. Sangamo Therapeutics Revenue in Gene Editing Technologies Business (2019-2024) & (US$ Million)
Table 61. Sangamo Therapeutics Recent Development
Table 62. Lonza Company Detail
Table 63. Lonza Business Overview
Table 64. Lonza Gene Editing Technologies Product
Table 65. Lonza Revenue in Gene Editing Technologies Business (2019-2024) & (US$ Million)
Table 66. Lonza Recent Development
Table 67. Transposagen Biopharmaceuticals Company Detail
Table 68. Transposagen Biopharmaceuticals Business Overview
Table 69. Transposagen Biopharmaceuticals Gene Editing Technologies Product
Table 70. Transposagen Biopharmaceuticals Revenue in Gene Editing Technologies Business (2019-2024) & (US$ Million)
Table 71. Transposagen Biopharmaceuticals Recent Development
Table 72. Editas Medicine Company Detail
Table 73. Editas Medicine Business Overview
Table 74. Editas Medicine Gene Editing Technologies Product
Table 75. Editas Medicine Revenue in Gene Editing Technologies Business (2019-2024) & (US$ Million)
Table 76. Editas Medicine Recent Development
Table 77. CRISPR Therapeutics Company Detail
Table 78. CRISPR Therapeutics Business Overview
Table 79. CRISPR Therapeutics Gene Editing Technologies Product
Table 80. CRISPR Therapeutics Revenue in Gene Editing Technologies Business (2019-2024) & (US$ Million)
Table 81. CRISPR Therapeutics Recent Development
Table 82. Agilent Technologies Company Detail
Table 83. Agilent Technologies Business Overview
Table 84. Agilent Technologies Gene Editing Technologies Product
Table 85. Agilent Technologies Revenue in Gene Editing Technologies Business (2019-2024) & (US$ Million)
Table 86. Agilent Technologies Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Editing Technologies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Gene Editing Technologies Market Share by Type: 2023 VS 2030
Figure 3. Double Strand Break Repair Features
Figure 4. Engineered Nucleases Features
Figure 5. Clustered Regularly Interspaced Short Palindromic Repeats Features
Figure 6. Global Gene Editing Technologies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Gene Editing Technologies Market Share by Application: 2023 VS 2030
Figure 8. Gene Therapy Case Studies
Figure 9. Eradicating Diseases Case Studies
Figure 10. Gene Editing Technologies Report Years Considered
Figure 11. Global Gene Editing Technologies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Gene Editing Technologies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Gene Editing Technologies Market Share by Region: 2023 VS 2030
Figure 14. Global Gene Editing Technologies Market Share by Players in 2023
Figure 15. Global Top Gene Editing Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing Technologies as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Gene Editing Technologies Revenue in 2023
Figure 17. North America Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Gene Editing Technologies Market Share by Country (2019-2030)
Figure 19. United States Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Gene Editing Technologies Market Share by Country (2019-2030)
Figure 23. Germany Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Gene Editing Technologies Market Share by Region (2019-2030)
Figure 31. China Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Gene Editing Technologies Market Share by Country (2019-2030)
Figure 39. Mexico Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Gene Editing Technologies Market Share by Country (2019-2030)
Figure 43. Turkey Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Gene Editing Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Thermo Fisher Scientific Revenue Growth Rate in Gene Editing Technologies Business (2019-2024)
Figure 46. Merck Revenue Growth Rate in Gene Editing Technologies Business (2019-2024)
Figure 47. Sangamo Therapeutics Revenue Growth Rate in Gene Editing Technologies Business (2019-2024)
Figure 48. Lonza Revenue Growth Rate in Gene Editing Technologies Business (2019-2024)
Figure 49. Transposagen Biopharmaceuticals Revenue Growth Rate in Gene Editing Technologies Business (2019-2024)
Figure 50. Editas Medicine Revenue Growth Rate in Gene Editing Technologies Business (2019-2024)
Figure 51. CRISPR Therapeutics Revenue Growth Rate in Gene Editing Technologies Business (2019-2024)
Figure 52. Agilent Technologies Revenue Growth Rate in Gene Editing Technologies Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
